Gene therapy: Applications and progress towards the clinic

Internal Medicine Journal

Volumn 34, Issue 11, 2004, Pages 621-625

  Trent, R J A ^a,b   Alexander, I E ^b,c  

^a ROYAL PRINCE ALFRED HOSPITAL   (Australia)

^b UNIVERSITY OF SYDNEY   (Australia)

^c CHILDREN S HOSPITAL AT WESTMEAD   (Australia)

Author keywords

Cellular therapies; Gene transfer; Retrovirus; SCID; Stem cell; Transduction

Indexed keywords

ANTILEUKEMIC AGENT; COMPLEMENTARY DNA; FC RECEPTOR; IMMUNOGLOBULIN; INTERLEUKIN RECEPTOR; RETROVIRUS VECTOR;

ACQUIRED IMMUNE DEFICIENCY SYNDROME; ADOPTIVE IMMUNOTHERAPY; BONE MARROW CELL; CANCER; CELL COUNT; CELL ISOLATION; CELL POPULATION; CLINICAL TRIAL; COMBINED IMMUNODEFICIENCY; COMBINED IMMUNODEFICIENCY X1; EX VIVO STUDY; GENE THERAPY; GENE TRANSFER; HUMAN; IN VIVO STUDY; LEUKEMIA; LMO 2 GENE; LONG TERM CARE; MEDICAL INFORMATION SYSTEM; MEDICAL TECHNOLOGY; NATURAL KILLER CELL; NONVIRAL GENE DELIVERY SYSTEM; ONCOGENE; PRIORITY JOURNAL; REVIEW; RISK BENEFIT ANALYSIS; SIDE EFFECT; STEM CELL; TARGET CELL; TREATMENT OUTCOME; VIRAL GENE DELIVERY SYSTEM;

AUSTRALIA; CLINICAL TRIALS; GENE THERAPY; GENE TRANSFER TECHNIQUES; HUMANS;

EID: 9744278252     PISSN: 14440903     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1445-5994.2004.00708.x     Document Type: Review

References (13)

1. Balicki D, Beutler E. Gene therapy of human disease. Medicine 2002; 81: 69-86.
2. Blaese RM, Culver KW, Miller AD, Carter CS, Fleisher T, Clerici M et al. T lymphocyte-directed gene therapy for ADA-SCID: initial trial results after 4 years. Science 1995; 270: 475-80.
3. Cavazzana-Calvo M, Hacein-Bey S, de Saint Basile G, Gross F, Yvon E, Nusbaum P et al. Gene therapy of human severe combined immunodeficiency (SCID) -X1 disease. Science 2000; 288: 669-72.
4. Journal of Gene Medicine. Gene therapy clinical trials database of over 6363 gene therapy studies worldwide [online]. John Wiley and Sons; 1999 [cited 17 March 2004]. Available from URL http:/ /www.wiley.co.uk/genmed/clinical
5. National Institutes of Health (NIH) Recombinant DNA Advisory Committee. List of gene therapy studies approved in the USA. Bethesda, MD: Office of Biotechnology Activities, NIH; 2000 [cited 17 March 2004]. Available from URL http:// www4.od.nih.gov/oba/rac/clinicaltrial.htm
6. Gene and Related Therapies Research Advisory Committee (GTRAP). List of Australian gene therapy studies. Canberra: National Health and Medical research Council; 2001 [cited 17 March 2004]. Available from URL http://www.nhmrc.gov.au/ research/gtrap.htm
7. Verma IM, Somia N. Gene therapy - promises, problems and prospects. Nature 1997; 389: 239-42.
8. Sarkar R, Tetreault R, Gao G, Wang L, Bell P, Chandler R et al. Total correction of hemophilia A mice with canine FVIII using an AAV 8 serotype. Blood 2004; 103: 1253-60.
9. Hacein-Bey-Abina S, Le Deist F, Carlier F, Bouneaud C, Hue C, de Villartay JP et al. Sustained correction of X-linked severe combined immunodeficiency by ex vivo gene therapy. N Engl J Med 2002; 346: 1185-93.
10. Hacein-Bey-Abina S, von Kalle C, Schmidt M, McCormack MP, Wulffraat N, Leboulch P et al. LMO2-associated clonal T cell proliferation in two patients after gene therapy for SCID-X1. Science 2003; 302: 415-9.
11. Aiuti A, Vai S, Mortellaro A, Casorati G, Ficara F, Andolfi G et al. Immune reconstitution in ADA-SCID after PBL gene therapy and discontinuation of enzyme replacement. Nat Med 2002; 8: 423-5.
12. Australasian Gene Therapy Society. Australasian Gene Therapy Society homepage 2002 [cited 17 March 2004]. Available from URL http://www.agts.org.au
13. Shi Y. Mammalian RNAi for the masses. Trends Genet 2003; 19: 9-12.